Male primary breast cancer found on FDG-PET/CT

James C. McEachen, Phillip H Kuo

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

We report a case of male primary breast cancer found incidentally on whole body FDG-PET/CT scanning with mammographic and histologic correlation. The relative lack of glandular activity in the male breast potentially increases the sensitivity of FDG-PET/CT for detection of male breast cancer. As in this case, even mild uptake in a male breast lesion should be regarded with suspicion. Although the incidental detection of breast masses on whole body FDG-PET/CT requires great vigilance, the modality provides both anatomic and physiologic data to help characterize primary breast cancer.

Original languageEnglish (US)
Pages (from-to)630-632
Number of pages3
JournalClinical Nuclear Medicine
Volume33
Issue number9
DOIs
StatePublished - Sep 2008
Externally publishedYes

Fingerprint

Male Breast Neoplasms
Breast
Breast Neoplasms

Keywords

  • Breast cancer
  • Male
  • PET
  • PET/CT
  • Synchronous tumors

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Male primary breast cancer found on FDG-PET/CT. / McEachen, James C.; Kuo, Phillip H.

In: Clinical Nuclear Medicine, Vol. 33, No. 9, 09.2008, p. 630-632.

Research output: Contribution to journalArticle

McEachen, James C. ; Kuo, Phillip H. / Male primary breast cancer found on FDG-PET/CT. In: Clinical Nuclear Medicine. 2008 ; Vol. 33, No. 9. pp. 630-632.
@article{0e782d6f278a40e3a2901a3d0945403d,
title = "Male primary breast cancer found on FDG-PET/CT",
abstract = "We report a case of male primary breast cancer found incidentally on whole body FDG-PET/CT scanning with mammographic and histologic correlation. The relative lack of glandular activity in the male breast potentially increases the sensitivity of FDG-PET/CT for detection of male breast cancer. As in this case, even mild uptake in a male breast lesion should be regarded with suspicion. Although the incidental detection of breast masses on whole body FDG-PET/CT requires great vigilance, the modality provides both anatomic and physiologic data to help characterize primary breast cancer.",
keywords = "Breast cancer, Male, PET, PET/CT, Synchronous tumors",
author = "McEachen, {James C.} and Kuo, {Phillip H}",
year = "2008",
month = "9",
doi = "10.1097/RLU.0b013e3181813528",
language = "English (US)",
volume = "33",
pages = "630--632",
journal = "Clinical Nuclear Medicine",
issn = "0363-9762",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Male primary breast cancer found on FDG-PET/CT

AU - McEachen, James C.

AU - Kuo, Phillip H

PY - 2008/9

Y1 - 2008/9

N2 - We report a case of male primary breast cancer found incidentally on whole body FDG-PET/CT scanning with mammographic and histologic correlation. The relative lack of glandular activity in the male breast potentially increases the sensitivity of FDG-PET/CT for detection of male breast cancer. As in this case, even mild uptake in a male breast lesion should be regarded with suspicion. Although the incidental detection of breast masses on whole body FDG-PET/CT requires great vigilance, the modality provides both anatomic and physiologic data to help characterize primary breast cancer.

AB - We report a case of male primary breast cancer found incidentally on whole body FDG-PET/CT scanning with mammographic and histologic correlation. The relative lack of glandular activity in the male breast potentially increases the sensitivity of FDG-PET/CT for detection of male breast cancer. As in this case, even mild uptake in a male breast lesion should be regarded with suspicion. Although the incidental detection of breast masses on whole body FDG-PET/CT requires great vigilance, the modality provides both anatomic and physiologic data to help characterize primary breast cancer.

KW - Breast cancer

KW - Male

KW - PET

KW - PET/CT

KW - Synchronous tumors

UR - http://www.scopus.com/inward/record.url?scp=55449134126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55449134126&partnerID=8YFLogxK

U2 - 10.1097/RLU.0b013e3181813528

DO - 10.1097/RLU.0b013e3181813528

M3 - Article

C2 - 18716515

AN - SCOPUS:55449134126

VL - 33

SP - 630

EP - 632

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 9

ER -